title: Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.
authors.affiliation: Institute for Molecular Biology, University of Essen GHS, FRG.
authors.forename: B
authors.initials: B
authors.lastname: Opalka
authors.forename: O
authors.initials: O
authors.lastname: Kloke
authors.forename: U
authors.initials: U
authors.lastname: Wandl
authors.forename: R
authors.initials: R
authors.lastname: Becher
authors.forename: N
authors.initials: N
authors.lastname: Niederle
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015139:Blotting, Southern; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000302:isolation & purification; D006412:Hematopoietic Stem Cells / Q000032:analysis; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D011994:Recombinant Proteins; D012074:Remission Induction
chemical_list: D004273:DNA, Neoplasm; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007371:Interferon-gamma